AKTUELLE RHEUMATOLOGIE

Scope & Guideline

Transforming rheumatology through shared knowledge and research.

Introduction

Immerse yourself in the scholarly insights of AKTUELLE RHEUMATOLOGIE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageMulti-Language
ISSN0341-051x
PublisherGEORG THIEME VERLAG KG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1978 to 2024
AbbreviationAKTUEL RHEUMATOL / Aktuelle Rheumatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRUDIGERSTR 14, D-70469 STUTTGART, GERMANY

Aims and Scopes

AKTUELLE RHEUMATOLOGIE focuses on advancing the understanding and treatment of rheumatic diseases through rigorous research and clinical studies. The journal encompasses a broad spectrum of topics related to rheumatology, including pathophysiology, treatment modalities, and patient management strategies.
  1. Exploration of Disease Mechanisms:
    The journal emphasizes research that investigates the underlying mechanisms of various rheumatic diseases, aiming to uncover novel pathophysiological insights that can inform treatment strategies.
  2. Clinical Trials and Treatment Efficacy:
    AKTUELLE RHEUMATOLOGIE publishes studies evaluating the efficacy and safety of new and existing therapies for rheumatic conditions, including biologics and traditional disease-modifying antirheumatic drugs (DMARDs).
  3. Patient-Centered Research:
    The journal features research on patient outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases, highlighting the importance of patient perspectives in clinical practice.
  4. Comorbidities and Risk Factors:
    Research on the comorbidities associated with rheumatic diseases, including cardiovascular risks and mental health issues, is a core focus, emphasizing the need for comprehensive care approaches.
  5. Innovative Diagnostic Approaches:
    The journal encourages studies that advance diagnostic methods, including imaging techniques and biomarkers, to improve early detection and monitoring of rheumatic diseases.
  6. Interdisciplinary Collaboration:
    AKTUELLE RHEUMATOLOGIE promotes interdisciplinary approaches, integrating insights from various medical fields to enhance the management of rheumatic diseases.
Recent publications in AKTUELLE RHEUMATOLOGIE indicate several emerging themes that reflect the evolving landscape of rheumatology research. These trends highlight the journal's responsiveness to contemporary challenges in the field.
  1. Telemedicine and Digital Health:
    There is a notable increase in studies exploring telemedicine and digital health interventions, particularly in response to the COVID-19 pandemic, emphasizing their role in enhancing patient care and accessibility.
  2. Microbiome Research in Rheumatology:
    An emerging focus on the relationship between the microbiome and rheumatic diseases is evident, with research investigating how gut health may influence disease activity and treatment responses.
  3. Gender Differences in Rheumatic Diseases:
    Recent papers are increasingly addressing the impact of gender on disease presentation, treatment efficacy, and outcomes, acknowledging the necessity of gender-sensitive approaches in rheumatology.
  4. Personalized Medicine and Biomarkers:
    Research on personalized medicine, including the identification of biomarkers for predicting disease progression and treatment responses, is gaining traction, reflecting a shift towards individualized patient care.
  5. Socioeconomic Factors in Disease Management:
    There is a growing interest in understanding how socioeconomic factors affect disease management, treatment adherence, and health outcomes in patients with rheumatic diseases.

Declining or Waning

While AKTUELLE RHEUMATOLOGIE continues to thrive in several research areas, some themes have seen a decline in focus over recent years. This section highlights those diminishing topics.
  1. Traditional Treatment Modalities:
    Research on conventional therapies, such as older DMARDs, appears to be waning as the field shifts towards biologics and targeted therapies, reflecting a growing emphasis on innovative treatment options.
  2. Historical Perspectives:
    Papers focusing on the historical aspects of rheumatology, while still valuable, are becoming less frequent as contemporary clinical research takes precedence in the journal's publications.
  3. Generalized Pain Management Strategies:
    Studies that provide broad, non-specific pain management strategies are declining in favor of more tailored, disease-specific approaches that address the unique needs of patients with rheumatic diseases.
  4. Basic Science Research:
    There seems to be a diminishing interest in purely basic science research without direct clinical implications, as the journal increasingly prioritizes studies that bridge the gap between laboratory findings and clinical application.

Similar Journals

BMC Rheumatology

Fostering dialogue and discovery in rheumatic diseases.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.

Archives of Rheumatology

Connecting global minds to transform rheumatologic care.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Pediatric Rheumatology

Empowering healthcare with innovative insights in pediatric rheumatology.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

Nature Reviews Rheumatology

Fostering innovation for better health outcomes.
Publisher: NATURE PORTFOLIOISSN: 1759-4790Frequency: 12 issues/year

Nature Reviews Rheumatology is a premier academic journal published by NATURE PORTFOLIO, dedicated to the field of rheumatology. With an impressive impact factor reflecting its high citation rate and relevance within the scientific community, it ranks in the Q1 category for rheumatology, showcasing its essential role in disseminating cutting-edge research and reviews. The journal serves as a vital resource for researchers, clinicians, and students alike, presenting comprehensive articles that cover the latest developments, therapeutic advancements, and emerging trends in rheumatic diseases. With access options, including open access, it ensures that valuable insights are within reach for all stakeholders in the field. Situated in the United Kingdom and intersecting with a global audience, Nature Reviews Rheumatology stands as an authoritative voice, fostering education and innovation to improve patient outcomes and enhance the understanding of rheumatological conditions.

Acta Reumatologica Portuguesa

Elevating rheumatology through collaboration and innovation.
Publisher: PUBLISAUDE-EDICOES MEDICAS LDAISSN: 0303-464XFrequency: 4 issues/year

Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.

Rheumatology Advances in Practice

Transforming insights into practice for rheumatology professionals.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

Open Access Rheumatology-Research and Reviews

Advancing Knowledge in Rheumatology, Open to All.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Exploring innovative therapies for better patient outcomes.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

JOURNAL OF RHEUMATOLOGY

Leading the Way in Rheumatology and Immunology Advancements
Publisher: J RHEUMATOL PUBL COISSN: 0315-162XFrequency: 12 issues/year

JOURNAL OF RHEUMATOLOGY, published by the J Rheumatol Publ Co, stands as a distinguished platform within the fields of rheumatology and immunology since its inception in 1974. With an impressive impact evidenced by its 2023 rankings—Q1 in Rheumatology and Q2 in both Immunology and Allergy—the journal has secured its position as a vital resource for researchers and practitioners alike. The journal is dedicated to advancing clinical and experimental knowledge in the pathogenesis, diagnosis, and management of rheumatic diseases, providing a rich repository of peer-reviewed articles that drive innovation in treatment protocols and patient care. Although it operates under a subscription model, the journal remains accessible to a broad audience committed to advancing their understanding of these critical areas. Located in Toronto, Canada, it continues to attract contributions from leading experts globally, making it an essential read for anyone keen on staying at the forefront of rheumatological research and practice.

ZEITSCHRIFT FUR RHEUMATOLOGIE

Advancing knowledge in rheumatology since 1974.
Publisher: SPRINGER HEIDELBERGISSN: 0340-1855Frequency: 10 issues/year

ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.